查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
下一代测序试剂盒市场 - 2018-2028F 全球行业规模、份额、趋势、机会和预测，按工作流程、测序类型、按应用、最终用户、地区和竞争细分
市场调查报告书
商品编码
1342716

下一代测序试剂盒市场 - 2018-2028F 全球行业规模、份额、趋势、机会和预测，按工作流程、测序类型、按应用、最终用户、地区和竞争细分

Next Generation Sequencing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Workflow, By Sequencing Type, By Usage Area, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计下一代测序试剂盒市场在预测期内将出现令人印象深刻的增长。这可以归因于 NGS 平台的不断进步，例如在技术中使用 iSeq 100 系统和 Ion Gene Studio S5 来更好地在全球范围内进行测试。同样，基于 NGS 的诊断测试的监管和报销方案的不断完善将进一步推动市场多年来的增长。此外，癌症患病率的不断上升以及新一代测序在癌症和其他传染病研究中的应用不断增加，预计将在预测期内带来显着增长。此外，便携式测序技术的不断发展，以及与主要参与者和研究机构在NGS技术进步方面不断加强的伙伴关係和合作，预计将在预测期内推动市场的增长。

NGS 不断进步

多年来，用于诊断囊性纤维化和镰状细胞病等一些罕见遗传病的 DNA 检测需求显着增加。此外，对能够以更低的成本提供更快结果的先进技术的需求不断增长，预计将在预测期内推动全球下一代测序试剂盒市场的增长。

对慢性病早期检测的需求不断增长

为了在早期阶段成功治疗癌症和其他传染病，需要NGS技术。因此，癌症和其他传染病（如结核病、脑膜炎球菌病等）患病率的不断上升是预计在预测期内推动 NGS 试剂盒市场增长的主要因素之一。例如，根据世界卫生组织（WHO）2022年2月提供的数据，癌症是全球主要死亡原因，2020年将导致近1000万人死亡。因此，分子诊断方法在临床微生物学中的使用有所增加近年来迅速发展。下一代测序 (NGS) 等分子诊断技术可以检测核酸的存在，并且该技术速度快，不需要在培养物中培养样本。研究人员可以使用下一代测序文本同时直接从样本中检测不同的疾病。此外，用NGS技术取代微阵列等传统技术进行快速检测将进一步增加多年来对NGS试剂盒的需求。例如，2022 年1 月，Illumina Inc. 与范德比尔特大学医学中心(VUMC) 的全资子公司Nashville Biosciences LLC 签订了一项多年期协议，通过大规模基因组学和建立卓越的实验室来加速药物开发。使用 Illumina 的下一代测序 (NGS) 平台的临床基因组资源。

近期发展

  • 2021年1月，华大基因地中海贫血基因检测试剂盒获得CE标誌批准，将用于地中海贫血等血红蛋白病的基因诊断或普通人群携带者筛查。
  • In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint药物.

可用的定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球下一代测序试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按工作流程（文库製备、簇生成、测序试剂套件）
    • 按测序类型（WES 和 WGS、靶向测序、长读测序、其他测序）
    • 按使用领域（临床、研究）
    • 按应用（肿瘤学、罕见疾病、遗传性疾病、生殖健康、其他）
    • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室等）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按工作流程
    • 按测序类型
    • 按使用区域
    • 按应用
    • 按最终用户
    • 按地区

第 6 章：北美下一代测序试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按工作流程（文库製备、簇生成、测序试剂套件）
    • 按测序类型（WES 和 WGS、靶向测序、长读测序、其他测序）
    • 按使用领域（临床、研究）
    • 按应用（肿瘤学、罕见疾病、遗传性疾病、生殖健康、其他）
    • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室等）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲下一代测序试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按工作流程（文库製备、簇生成、测序试剂套件）
    • 按测序类型（WES 和 WGS、靶向测序、长读测序、其他测序）
    • 按使用领域（临床、研究）
    • 按应用（肿瘤学、罕见疾病、遗传性疾病、生殖健康、其他）
    • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室等）
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太地区下一代测序试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按工作流程（文库製备、簇生成、测序试剂套件）
    • 按测序类型（WES 和 WGS、靶向测序、长读测序、其他测序）
    • 按使用领域（临床、研究）
    • 按应用（肿瘤学、罕见疾病、遗传性疾病、生殖健康、其他）
    • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室等）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章：南美下一代测序试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按工作流程（文库製备、簇生成、测序试剂套件）
    • 按测序类型（WES 和 WGS、靶向测序、长读测序、其他测序）
    • 按使用领域（临床、研究）
    • 按应用（肿瘤学、罕见疾病、遗传性疾病、生殖健康、其他）
    • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室等）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲下一代测序试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按工作流程（文库製备、簇生成、测序试剂套件）
    • 按测序类型（WES 和 WGS、靶向测序、长读测序、其他测序）
    • 按使用领域（临床、研究）
    • 按应用（肿瘤学、罕见疾病、遗传性疾病、生殖健康、其他）
    • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室等）
    • 按国家/地区
  • MEA：国家分析
    • 南非下一代测序试剂盒
    • 沙特阿拉伯下一代测序试剂盒
    • 阿联酋下一代测序试剂盒

第 11 章：市场动态

  • 司机
    • NGS 不断进步
    • 对慢性病早期检测的需求不断增长
  • 挑战
    • 缺乏熟练的专业人员和基础设施
    • 严格的规定

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球下一代测序试剂盒市场：SWOT 分析

第 14 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • BGI Group.
    • Creative Biogene
    • Danaher.
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Illumina, Inc.
    • Oxford Nanopore Technologies plc.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer Inc.

第 16 章：战略建议

简介目录
Product Code: 14801

Next Generation Sequencing Kits market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advancements NGS platform such as using the iSeq 100 system and Ion Gene Studio S5 in the technology for better testing across the globe. Similarly, the growing improvement of regulatory and reimbursement scenarios for NGS-based diagnostics tests will further drive the growth of the market over the years. Additionally, the growing prevalence of cancer and increasing applications of next-generation sequencing in cancer and other infectious diseases research is expected to create significant growth during the forecasted period. Moreover, the growing development of portable sequencing technologies along with growing partnerships & collaborations for technological advancements in NGS with major key players and research institutes is expected to drive the growth of the market during the forecast period.

Growing Advancements in NGS

Growing demand for DNA testing for the diagnosis of some rare genetic diseases such as cystic fibrosis and sickle cell diseases has significantly increased over the years. Additionally, the growing demand for advanced technology which can provide faster results at less cost is expected to drive the growth of global next generation sequencing kits market during the forecast period.

For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing helps scientists to find a patient's complete DNA makeup which contains information about everything from eye color to inherited diseases and it is vital for diagnosing patients with diseases rooted in their DNA. Also, the growing genome mapping program linked to different types of diseases and understanding inherited disorders and their treatment will further drive the growth of the market during the forecast period. Public, private, and non-profit interests have also invested largely in the technology to treat novel diseases and improve diagnostics and healthcare. Increased availability of funding supported by the next-generation sequencing market will further enhance the demand for the NGS kits market during the forecast period.

Growing Demand for Early Detection of Chronic Diseases

For the successful treatment of cancer and other infectious diseases in the early stage, NGS technology is required. So, the growing prevalence of cancer and other infectious diseases such as tuberculosis, meningococcal diseases, etc is one of the major factors expected to drive the growth of the NGS kits market during the forecast period. For instance, according to the data provided by World Health Organization (WHO) in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. So, the usage of molecular diagnostics methods in clinical microbiology has increased rapidly in recent years. Molecular diagnostic technologies such as next-generation sequencing (NGS) can detect the presence of nucleic acids and this technology are quick and doesn't require specimen growth in culture. The researchers can use next-generation sequencing texts to detect different diseases concurrently and directly from a sample. Additionally, replacing the traditional technologies such as microarrays by NGS technology for fast detection will further enhance the demand for NGS kits over the years. For instance, in January 2022, Illumina Inc. and Nashville Biosciences LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinical-genomic resource using Illumina's next-generation sequencing (NGS) platforms.

Market Segmentation

Global Next Generation Sequencing Kits market can be segmented on the basis of workflow, sequencing type, usage area, application, end users and by region. Based on the workflow, the market is further segmented into library preparation, cluster generation, and sequencing reagents kits. Based on sequencing type, the market can be segmented into WES and WGS, targeted sequencing, long read sequencing, and other sequencing. Based on the usage area, the market can be bifurcated into clinical and research. Based on application, the market can be further grouped into oncology, rare diseases, genetic disorders, reproductive health, and others. Based on end users, the market can be grouped into academic and research institutions, pharmaceutical and biotechnology companies, clinical, diagnostic laboratories, and others. Regionally, in terms of region North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of country, the United States dominated the global next generation sequencing kits market on account of the increasing demand for early detection of infectious diseases in the country.

Recent Development

  • In January 2021, BGI group received the CE mark approval for the Thalassemia Gene Detection Kit which will be used for the genetic diagnosis of thalassemia and other hemoglobinopathy or for general population carrier screening.
  • In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint Medicines.

Market Players

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.

Report Scope

In this report, global Next Generation Sequencing Kits market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing Kits Market, By Workflow:

  • Library Preparation
  • Cluster Generation
  • Sequencing Reagents Kits

Next Generation Sequencing Kits Market, By Sequencing Type:

  • WES and WGS
  • Targeted Sequencing
  • Long Read Sequencing
  • Other Sequencing

Next Generation Sequencing Kits Market, By Usage Area:

  • Clinical
  • Research

Next Generation Sequencing Kits, By Application:

  • Oncology
  • Rare Diseases
  • Genetic Disorders
  • Reproductive Health
  • Others

Next Generation Sequencing Kits, By End User:

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Others

Next Generation Sequencing Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Kits Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 5.2.3. By Usage Area (Clinical, Research)
    • 5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Workflow
    • 5.3.2 By Sequencing Type
    • 5.3.3 By Usage Area
    • 5.3.4 By Application
    • 5.3.5 By End User
    • 5.3.6 By Region

6. North America Next Generation Sequencing Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 6.2.3. By Usage Area (Clinical, Research)
    • 6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Workflow
        • 6.3.1.2.2. By Sequencing Type
        • 6.3.1.2.3. By Usage Area
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Next Generation Sequencing Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Workflow
        • 6.3.2.2.2. By Sequencing Type
        • 6.3.2.2.3. By Usage Area
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Workflow
        • 6.3.3.2.2. By Sequencing Type
        • 6.3.3.2.3. By Usage Area
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Next Generation Sequencing Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 7.2.3. By Usage Area (Clinical, Research)
    • 7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next Generation Sequencing Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Workflow
        • 7.3.1.2.2. By Sequencing Type
        • 7.3.1.2.3. By Usage Area
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Next Generation Sequencing Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Workflow
        • 7.3.2.2.2. By Sequencing Type
        • 7.3.2.2.3. By Usage Area
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Workflow
        • 7.3.3.2.2. By Sequencing Type
        • 7.3.3.2.3. By Usage Area
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Next Generation Sequencing Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Workflow
        • 7.3.4.2.2. By Sequencing Type
        • 7.3.4.2.3. By Usage Area
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Next Generation Sequencing Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Workflow
        • 7.3.5.2.2. By Sequencing Type
        • 7.3.5.2.3. By Usage Area
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Next Generation Sequencing Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 8.2.3. By Usage Area (Clinical, Research)
    • 8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Workflow
        • 8.3.1.2.2. By Sequencing Type
        • 8.3.1.2.3. By Usage Area
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Next Generation Sequencing Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Workflow
        • 8.3.2.2.2. By Sequencing Type
        • 8.3.2.2.3. By Usage Area
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Next Generation Sequencing Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Workflow
        • 8.3.3.2.2. By Sequencing Type
        • 8.3.3.2.3. By Usage Area
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Workflow
        • 8.3.4.2.2. By Sequencing Type
        • 8.3.4.2.3. By Usage Area
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Next Generation Sequencing Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Workflow
        • 8.3.5.2.2. By Sequencing Type
        • 8.3.5.2.3. By Usage Area
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Next Generation Sequencing Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 9.2.3. By Usage Area (Clinical, Research)
    • 9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Workflow
        • 9.3.1.2.2. By Sequencing Type
        • 9.3.1.2.3. By Usage Area
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Workflow
        • 9.3.2.2.2. By Sequencing Type
        • 9.3.2.2.3. By Usage Area
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Workflow
        • 9.3.3.2.2. By Sequencing Type
        • 9.3.3.2.3. By Usage Area
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Next Generation Sequencing Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 10.2.3. By Usage Area (Clinical, Research)
    • 10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Workflow
        • 10.3.1.2.2. By Sequencing Type
        • 10.3.1.2.3. By Usage Area
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Workflow
        • 10.3.2.2.2. By Sequencing Type
        • 10.3.2.2.3. By Usage Area
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Next Generation Sequencing Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Workflow
        • 10.3.3.2.2. By Sequencing Type
        • 10.3.3.2.3. By Usage Area
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing advancement in NGS
    • 11.1.2 Growing Demand for Early Detection of Chronic Diseases
  • 11.2. Challenges
    • 11.2.1 Lack of skilled professionals and infrastructure
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Next Generation Sequencing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
    • 15.5.1. Agilent Technologies, Inc.
    • 15.5.2. Bio-Rad Laboratories, Inc.
    • 15.5.3. BGI Group.
    • 15.5.4. Creative Biogene
    • 15.5.5. Danaher.
    • 15.5.6. F. Hoffmann-La Roche Ltd.
    • 15.5.7. Hologic, Inc.
    • 15.5.8. Illumina, Inc.
    • 15.5.9. Oxford Nanopore Technologies plc.
    • 15.5.10. Pacific Biosciences of California, Inc.
    • 15.5.11. PerkinElmer Inc.

16. Strategic Recommendations